Cencora, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

CEO

Robert P. Mauch

CEORobert P. Mauch

Employees

51,000

Employees51,000

Headquarters

Conshohocken, Pennsylvania

HeadquartersConshohocken, Pennsylvania

Founded

1947

Founded1947

Employees

51,000

Employees51,000

COR Key Statistics

Market cap

60.53B

Market cap60.53B

Price-Earnings ratio

23.40

Price-Earnings ratio23.40

Dividend yield

0.75%

Dividend yield0.75%

Average volume

1.45M

Average volume1.45M

High today

$317.32

High today$317.32

Low today

$313.13

Low today$313.13

Open price

$314.72

Open price$314.72

Volume

78.96K

Volume78.96K

52 Week high

$377.54

52 Week high$377.54

52 Week low

$244.82

52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $317.18. The company's market cap stands at 60.53B, with a P/E ratio of 23.40 and a dividend yield of 0.75%.

As of 2026-08-21, Cencora, Inc.(COR) stock has fluctuated between $313.13 and $317.32. The current price stands at $317.18, placing the stock +1.3% above today's low and -0.0% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 78.96K, against a daily average of 1.45M.

During the past year, Cencora, Inc.(COR) stock moved between $244.82 at its lowest and $377.54 at its peak.

COR News

Benzinga 2d

$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga

...

Nasdaq 2d

Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.

Key Points This pair of stocks offer inflation exposure but they don't need rising prices to succeed. McKesson can benefit when certain pharmaceutical prices...

TipRanks 2d

Cencora initiated with a Sector Perform at RBC Capital

RBC Capital initiated coverage of Cencora (COR) with a Sector Perform rating and $330 price target The company’s “pharma-aligned and integrated platform” will b...

Analyst ratings

74%

of 19 ratings

Buy

73.7%

Hold

26.3%

Sell

More COR News

Simply Wall St 6d

Do Strong Q3 Results And Bigger Credit Lines Change The Bull Case For Cencora?

Cencora, Inc. recently reported third-quarter 2026 results, with sales of US$84.75 billion and net income of US$763.52 million, while also declaring a US$0.60 q...

TipRanks 7d

Cencora Announces Resignation of Board Member Lorence Kim

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.